BEIJING SHENOGEN PHARMA GROUP LTD.

City:

Beijing

Country:

China

Published Applications:

Last publication date:

2022-12-08

Patent Grants:

Last grant date:

2025-01-28

Top Inventors for applications by BEIJING SHENOGEN PHARMA GROUP LTD.

These are the the leading inventors for applications assigned to BEIJING SHENOGEN PHARMA GROUP LTD.:

Kun Meng 6 Beijing, China
Hongxia Ding 3 Beijing, China
Jin LI 2 Beijing, China
Xiaoming CHEN 1 Beijing, China

Jing Wang 1 Beijing, China
Lixin Fan 1 Beijing, China
Yonggang Wang 1 Beijing, China
Mingji Jin 1 Beijing, China

DONG WEI 1 Beijing, China
Ya TUO 1 Beijing, China
Feng Chen 1 Beijing, China
Huting Wang 1 Beijing, China

Yueqiu SHEN 1 Beijing, China
Lei Zhang 1 Beijing, China
Yong Peng 1 Beijing, China
Xiao SHANG 1 Beijing, China

Jing Wang 1 Winchester, MA United States
Jiaojiao Wang 1 Beijing, China
Congya ZHOU 1 Beijing, China
Lei Liu 1 Beijing, China

Shu LI 1 Beijing, China
Xueming QIAN 1 Beijing, China
Lu LI 1 Beijing, China
Dongliang Mo 1 Beijing, China

Ranran Zhang 1 Beijing, China
Hua Yao 1 Beijing, China
Cheng Tang 1 Beijing, China

Recent patent applications by BEIJING SHENOGEN PHARMA GROUP LTD.

BEIJING SHENOGEN PHARMA GROUP LTD. based in Beijing, CN has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2022-12-08 ✅ Patent 12,209,074 granted on 2025-01-28

US20220388977A1

Chemistry; metallurgy

SHP2 phosphatase allosteric inhibitor

#2 | 2022-08-11

US20220249370A1

Human necessities

NANO-MICELLE PREPARATION OF ICARITIN AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF

#3 | 2016-02-18 ✅ Patent 10,233,249 granted on 2019-03-19

US20160046721A1

Chemistry; metallurgy

Antibodies and methods for treating estrogen receptor-associated diseases

#4 | 2015-01-08 ✅ Patent 9,221,781 granted on 2015-12-29

US20150011618A1

Chemistry; metallurgy

Synthesis of polyhydroxy chromenone compounds and their anti-tumor effects

#5 | 2014-12-04 ✅ Patent 9,301,942 granted on 2016-04-05

US20140357876A1

Human necessities

Use of icaritin for the preparation of composition for treating cancer

#6 | 2013-11-14 ✅ Patent 9,090,583 granted on 2015-07-28

US20130303544A1

Chemistry; metallurgy

Benzopyrone estrogen receptor regulator

Also check out BEIJING SHENOGEN PHARMA GROUP LTD.'s (Beijing, China) applicant profile with 4 patent applications submitted.

AssigneeID:

45423 ⎘